[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPH08175959A - Skin cosmetic - Google Patents

Skin cosmetic

Info

Publication number
JPH08175959A
JPH08175959A JP32534094A JP32534094A JPH08175959A JP H08175959 A JPH08175959 A JP H08175959A JP 32534094 A JP32534094 A JP 32534094A JP 32534094 A JP32534094 A JP 32534094A JP H08175959 A JPH08175959 A JP H08175959A
Authority
JP
Japan
Prior art keywords
cosmetic
skin
compound
wrinkles
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP32534094A
Other languages
Japanese (ja)
Inventor
Takatoshi Murase
孝利 村瀬
Tadashi Hase
正 長谷
Yoshinori Takema
吉則 武馬
Ayumi Ogawa
亜由美 小河
Hiroyuki Osu
弘之 大須
Ichirou Tokimitsu
一郎 時光
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP32534094A priority Critical patent/JPH08175959A/en
Publication of JPH08175959A publication Critical patent/JPH08175959A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PURPOSE: To provide a skin cosmetic containing a benzoic acid anilide compound and effective for suppressing the wrinkling and pigmentation of the skin. CONSTITUTION: This cosmetic contains a compound of formula (R<1> is H or t-butyl; R<2> is H, a 1-5C alkyl or an acyl) or its salt as an active component in an amount of 0.001-20wt.%, preferably 0.05-5wt.%. The suppression effect on the wrinkle and spots can be improved by incorporating the cosmetic with other conventional anti-inflammatory agent (e.g. allantoin), an antioxidant, etc. It can be prepared in the form of an O/W-type or W/O-type emulsified cosmetic, cream, cosmetic milky lotion, face lotion, oily cosmetic, pack, foundation, etc., by properly compounding with conventional cosmetic components. An example of the compound of formula is 4-hydroxy-N-(2-hydroxyphenyl) benzoic acid amide.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は皮膚化粧料に関し、詳細
には皮膚のシワ形成及び色素沈着を抑制し、皮膚の老化
を防止する化粧料に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin cosmetic, and more particularly to a skin cosmetic which suppresses skin wrinkling and pigmentation and prevents skin aging.

【0002】[0002]

【従来の技術】健康で美しい肌を保つことは、老若男女
を問わず重大な関心事となっている。
2. Description of the Related Art Maintaining healthy and beautiful skin has become a serious concern for people of all ages.

【0003】ところが、肌は加齢、紫外線、温・湿度、
疾病、ストレス、食習慣等により影響を受け、老化、諸
機能の低下、その他種々のトラブルが発生する。皮膚の
老化の典型は「シワ」や「シミ(色素沈着)」の形成で
あり、これらは特に女性にとって美容上の大きな悩みの
一つとなっている。
However, the skin is aged, ultraviolet rays, temperature and humidity,
It is affected by diseases, stress, eating habits, etc., causing aging, deterioration of various functions, and various other troubles. Typical of skin aging is the formation of "wrinkles" and "spots" (pigmentation), which are one of the major cosmetic problems especially for women.

【0004】これらのうち、真皮のトラブルの一つであ
るシワは、加齢や太陽光線による皮膚の老化(光老化)
により発生する。老化のメカニズムは明らかではない
が、皮膚の場合、生体の最外層に位置して、生体防御の
最前線の役割を担っていることから、環境因子による障
害の蓄積が皮膚加齢現象に大きく作用していると考えら
れる。とりわけ紫外線は皮膚加齢、シワ形成に関与する
最大の環境因子と考えられる。すなわち、紫外線により
産生されるフリーラジカル(特に活性酸素)は日焼けな
どの急性炎症のみでなく、慢性的に繰り返されることに
より光老化を誘発することが知られている。詳細には紫
外線により発生する各種フリーラジカルや活性酸素(ス
ーパーオキシド、ハイドロキシラジカル、一重項酸素
等)は真皮成分のDNA−蛋白クロスリンク(架橋結
合)、コラーゲンやエラスチンなどの蛋白クロスリンク
の障害、変性、SODなどの抗酸化酵素の不活化、細胞
成分の膜脂質過酸化とこれによる細胞機能の劣化などを
惹起し、その結果として老化、シワが形成されると考え
られている(フレグランス ジャーナル,11巻,49
−54,1992)。
Of these, wrinkles, which are one of the problems of the dermis, are aging of the skin due to aging and sunlight (photoaging).
Caused by. Although the mechanism of aging is not clear, in the case of the skin, it is located in the outermost layer of the body and plays a role of the front line of biological defense.Accordingly, the accumulation of disorders due to environmental factors has a significant effect on the skin aging phenomenon. it seems to do. In particular, ultraviolet rays are considered to be the largest environmental factor involved in skin aging and wrinkle formation. That is, it is known that free radicals (particularly active oxygen) produced by ultraviolet rays induce not only acute inflammation such as sunburn but also photoaging by being chronically repeated. Specifically, various free radicals and active oxygen (superoxide, hydroxy radicals, singlet oxygen, etc.) generated by ultraviolet rays are DNA-protein crosslinks (crosslinking bonds) of dermal components, obstacles to protein crosslinks such as collagen and elastin, It is considered that denaturation, inactivation of antioxidant enzymes such as SOD, peroxidation of membrane lipids of cell components and deterioration of cell function due to this are caused, and as a result, aging and wrinkles are formed (Fragrance Journal, Volume 11, 49
-54, 1992).

【0005】そこで、このようなシワの形成を予防する
ために、従来、ビタミンEのような抗酸化剤の利用(特
開昭61−215309号公報、特開昭62−2631
10号公報)、各種植物抽出物の利用(特開昭62−6
1924号公報、特開昭63−174911号公報、特
開平6−65043号公報等)、コラーゲン等細胞外マ
トリクスの制御剤の利用(特開平4−74016号公
報、特開平3−20206号公報等)、レチノイン酸や
α−ヒドロキシ酸の利用などが提案されてきた。
Therefore, in order to prevent the formation of such wrinkles, conventionally, an antioxidant such as vitamin E has been used (Japanese Patent Laid-Open No. 61-215309, Japanese Patent Laid-Open No. 62-2631).
No. 10), the use of various plant extracts (JP-A-62-6).
1924, JP-A-63-174911, JP-A-6-65043, etc.), the use of extracellular matrix control agents such as collagen (JP-A-4-74016, JP-A-3-20206, etc.) ), The use of retinoic acid or α-hydroxy acid has been proposed.

【0006】しかしながら、このような従来の手段のシ
ワ予防改善効果は十分でなかった。
[0006] However, the effect of preventing and improving the wrinkles of such conventional means is not sufficient.

【0007】一方、シミのような色素沈着は、表皮内で
メラノサイトにより合成されるメラニン色素が増加する
ことにより発生し、その発症機序については紫外線、女
性ホルモン、遺伝的要因などの関与が指摘されている
が、未だ十分解明されていない。そのため、これまでは
メラニンの生成抑制や既成メラニンの還元などを目的と
した薬剤が美白剤として研究されてきており、これまで
にアルブチンやコウジ酸、ビタミンC、カンゾウエキス
(特開昭63−23809号公報、特開平1−1497
06号公報)、カッコン(特開昭64−16709号公
報)、ヒドロキシスチルベン(特開昭64−38009
号公報)、3−ヒドロキシクロモン(特開昭55−11
1410号公報、特開昭55−143908号公報)、
イソフラボン(特開昭58−225004号公報)など
が開発されている。しかし、実際の化粧品への配合性に
優れ、かつ美白効果の高い物質はほとんど無いのが実情
である。
On the other hand, pigmentation such as spots occurs due to an increase in melanin pigment synthesized by melanocytes in the epidermis, and it is pointed out that ultraviolet rays, female hormones, genetic factors, etc. are involved in the pathogenic mechanism. However, it has not been fully clarified yet. Therefore, drugs for the purpose of suppressing the production of melanin and reducing established melanin have been studied as whitening agents, and arbutin, kojic acid, vitamin C, licorice extract (Japanese Patent Laid-Open No. 63-23809). Japanese Laid-Open Patent Publication No. 1-1497
No. 06), Cuckon (JP-A-64-16709), hydroxystilbene (JP-A-64-38009).
No.), 3-hydroxychromone (JP-A-55-11)
1410, JP-A-55-143908),
Isoflavones (JP-A-58-225004) and the like have been developed. However, the fact is that there are almost no substances that are highly compoundable in actual cosmetics and have a high whitening effect.

【0008】[0008]

【発明が解決しようとする課題】従って本発明の目的
は、皮膚の老化すなわちシワ及び色素沈着の形成予防及
び改善に有効な皮膚化粧料を提供することにある。
SUMMARY OF THE INVENTION It is, therefore, an object of the present invention to provide a skin cosmetic effective for preventing and improving skin aging, that is, formation of wrinkles and pigmentation.

【0009】[0009]

【課題を解決するための手段】斯かる実情に鑑み本発明
者らは鋭意研究を行った結果、下記一般式(1)で表わ
される安息香酸アニリド類又はその塩を配合すれば、優
れたシワ及び色素沈着の形成予防及び改善作用を有する
皮膚化粧料が得られることを見出し本発明を完成した。
In view of such circumstances, the present inventors have conducted diligent research and as a result, when an anilide benzoate represented by the following general formula (1) or a salt thereof is blended, excellent wrinkles are obtained. Further, they have found that a skin cosmetic having an effect of preventing and improving the formation of pigmentation can be obtained and completed the present invention.

【0010】すなわち本発明は下記一般式(1)That is, the present invention is represented by the following general formula (1)

【0011】[0011]

【化2】 Embedded image

【0012】〔式中、R1 は水素原子又はt−ブチル基
を示し、R2 は水素原子又は炭素数1〜5のアルキル若
しくはアシル基を示す〕で表わされる安息香酸アニリド
類又はその塩を含有する皮膚化粧料を提供するものであ
る。
A benzoyl anilide or a salt thereof represented by the formula: wherein R 1 represents a hydrogen atom or a t-butyl group, and R 2 represents a hydrogen atom or an alkyl or acyl group having 1 to 5 carbon atoms. It is intended to provide a skin cosmetic containing the same.

【0013】本発明で用いる安息香酸アニリド類は、前
記一般式(1)で表わされるものであるが、この式中、
2 の具体例としては、水素原子;メチル基、エチル
基、n−プロピル基、イソプロピル基、n−ブチル基、
イソブチル基、sec−ブチル基、t−ブチル基、n−
ペンチル基、イソペンチル基等のアルキル基;ホルミル
基、アセチル基、プロピオニル基、n−ブチリル基、イ
ソブチリル基、n−バレリル基、イソバレリル基、ピバ
リル基等のアシル基が挙げられるが、このうち水素原子
が特に好ましい。
The benzoic acid anilide used in the present invention is represented by the above-mentioned general formula (1).
Specific examples of R 2 include hydrogen atom; methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group,
Isobutyl group, sec-butyl group, t-butyl group, n-
Alkyl groups such as pentyl group and isopentyl group; formyl group, acetyl group, propionyl group, n-butyryl group, isobutyryl group, n-valeryl group, isovaleryl group, pivalyl group and other acyl groups, among which hydrogen atom Is particularly preferable.

【0014】上記一般式(1)で表わされる安息香酸ア
ニリド類の中でも具体的には特に4−ヒドロキシ−N−
(2−ヒドロキシフェニル)安息香酸アミド(化合物
1)、4−ヒドロキシ−N−(3−ヒドロキシフェニ
ル)ベンズアミド(化合物2)、4−ヒドロキシ−N−
(4−ヒドロキシフェニル)ベンズアミド(化合物
3)、3,5−ジ−t−ブチル−4−ヒドロキシ−N−
(4−ヒドロキシフェニル)ベンズアミド(化合物
4)、3,5−ジ−t−ブチル−4−ヒドロキシ−N−
(3−ヒドロキシフェニル)ベンズアミド(化合物
5)、3,5−ジ−t−ブチル−4−ヒドロキシ−N−
(2−ヒドロキシフェニル)ベンズアミド(化合物6)
等が好ましいが、何らこれらに限定されるものではな
い。
Among the benzoic acid anilides represented by the general formula (1), specifically 4-hydroxy-N- is particularly preferable.
(2-Hydroxyphenyl) benzoic acid amide (Compound 1), 4-hydroxy-N- (3-hydroxyphenyl) benzamide (Compound 2), 4-hydroxy-N-
(4-Hydroxyphenyl) benzamide (Compound 3), 3,5-di-t-butyl-4-hydroxy-N-
(4-Hydroxyphenyl) benzamide (Compound 4), 3,5-di-t-butyl-4-hydroxy-N-
(3-Hydroxyphenyl) benzamide (Compound 5), 3,5-di-t-butyl-4-hydroxy-N-
(2-Hydroxyphenyl) benzamide (Compound 6)
However, the present invention is not limited to these.

【0015】安息香酸アニリド類(1)の一部は公知の
化合物であり公知の方法により製造することができる
〔文献:特開平6−72866号及び特願平6−126
278号〕。しかしながら、当該化合物が皮膚老化防止
作用を持つことについては知られていない。
A part of the benzoic acid anilides (1) is a known compound and can be produced by a known method [Reference: JP-A-6-72866 and Japanese Patent Application No. 6-126].
278]. However, it is not known that the compound has a skin antiaging effect.

【0016】安息香酸アニリド類は、製造手段により、
又は使用目的により、水和物、溶媒和物、塩の形態で安
定させる場合もあるが、本発明においてはこれらのいず
れも使用することができる。塩としてはナトリウム、カ
リウム等のアルカリ金属塩、アルカリ土類金属塩、アミ
ン塩等が挙げられる。
The anilide benzoates can be produced by the production means.
Alternatively, depending on the purpose of use, it may be stabilized in the form of a hydrate, a solvate, or a salt, and any of these may be used in the present invention. Examples of the salt include alkali metal salts such as sodium and potassium, alkaline earth metal salts, amine salts and the like.

【0017】本発明の皮膚化粧料における上記安息香酸
アニリド類又はその塩の配合量は一般的に0.001〜
20重量%程度とすることが好ましく、0.05〜5重
量%とすることがより好ましい。
The amount of the above-mentioned anilide benzoate or a salt thereof in the skin cosmetic of the present invention is generally 0.001 to
The amount is preferably about 20% by weight, more preferably 0.05 to 5% by weight.

【0018】本発明の皮膚化粧料は上記必須成分の他、
アラントイン、ビタミンE誘導体、グリチルリチン、ア
スコルビン酸誘導体等公知の抗炎症剤、抗酸化剤などを
添加することによりシワやシミの形成抑制効果の向上を
はかることができる。
The skin cosmetic of the present invention contains, in addition to the above essential components,
The addition of known anti-inflammatory agents such as allantoin, vitamin E derivatives, glycyrrhizin and ascorbic acid derivatives, antioxidants, etc. can improve the effect of suppressing the formation of wrinkles and spots.

【0019】更に、本発明の皮膚化粧料には、必要に応
じて通常の化粧料に配合される成分、例えばヒアルロン
酸やセラミドなどの保湿剤、紫外線吸収剤、アルコール
類、キレート剤、ワセリン、ラノリン、セレシン、マイ
クロクリスタリンワックス、カルナウバロウ、キャンデ
リラロウ、高級脂肪酸、高級アルコール等の固形・半固
形油分;水溶性及び油溶性ポリマー;無機及び有機顔
料、シリコーン又はフッ素化合物で処理された無機及び
有機顔料、有機染料等の色剤;アニオン性活性剤、カチ
オン性活性剤、非イオン性活性剤、ジメチルポリシロキ
サン・ポリオキシアルキレン共重合体、ポリエーテル変
性シリコーン等の界面活性剤;その他水、防腐剤、酸化
防止剤、色素、増粘剤、pH調整剤、香料、血行促進剤、
冷感剤、制汗剤、殺菌剤、皮膚賦活剤などを、本発明の
効果を損なわない範囲で、適宜配合することができる。
Further, the skin cosmetic composition of the present invention contains, if necessary, components that are added to ordinary cosmetic compositions, such as moisturizers such as hyaluronic acid and ceramide, ultraviolet absorbers, alcohols, chelating agents, vaseline, Solid and semi-solid oils such as lanolin, ceresin, microcrystalline wax, carnauba wax, candelilla wax, higher fatty acids, higher alcohols; water-soluble and oil-soluble polymers; inorganic and organic pigments, inorganic and organic treated with silicone or fluorine compounds Colorants such as pigments and organic dyes; anionic activators, cationic activators, nonionic activators, surfactants such as dimethylpolysiloxane / polyoxyalkylene copolymers and polyether modified silicones; other water, antiseptic Agents, antioxidants, pigments, thickeners, pH adjusters, fragrances, blood circulation promoters,
A cooling sensation agent, an antiperspirant, a bactericidal agent, a skin activating agent, etc. can be appropriately added within a range that does not impair the effects of the present invention.

【0020】本発明の化粧料は種々の用途及び形態、例
えば油/水型、水/油型の乳化化粧料、クリーム、化粧
乳液、化粧水、油性化粧料、パック剤、ファンデーショ
ン等として用いることができる。また本発明の化粧料
は、常法により製造することができる。本発明の皮膚化
粧料は一般皮膚化粧料に限定されるものではなく、医薬
部外品、薬用化粧料等を包含するものである。
The cosmetics of the present invention can be used in various applications and forms such as oil / water type, water / oil type emulsified cosmetics, creams, lotions, lotions, oily cosmetics, packs, foundations and the like. You can Further, the cosmetic of the present invention can be manufactured by a conventional method. The skin cosmetic of the present invention is not limited to general skin cosmetics, but includes quasi drugs, medicated cosmetics, and the like.

【0021】[0021]

【発明の効果】本発明の皮膚化粧料は、皮膚の老化予防
・改善効果、すなわちシワ、色素沈着(シミ等)の形成
を予防し、改善する効果に優れるものである。特に本発
明化粧料は紫外線照射により生じるシワの形成、色素沈
着を有効に抑制する。
The skin cosmetic of the present invention is excellent in the effect of preventing and improving skin aging, that is, the effect of preventing and improving the formation of wrinkles and pigmentation (spots, etc.). In particular, the cosmetic of the present invention effectively suppresses the formation of wrinkles and pigmentation caused by irradiation with ultraviolet rays.

【0022】[0022]

【実施例】次に実施例を挙げて本発明を詳細に説明する
が、本発明はこれらの実施例に限定されるものではな
い。
The present invention will be described in detail below with reference to examples, but the present invention is not limited to these examples.

【0023】合成例1 o−アミノフェノール(10.99g,100.0mmo
l) をピリジン−クロロホルム(5:1)混合溶媒(1
80ml)中に溶解し、−20℃で撹拌しp-アセトキシ安
息香酸クロリド(10.0g,50.0mmol)をクロロ
ホルム(200ml)中に溶解したものを、3.5時間か
けてゆっくり滴下した。滴下終了よりさらに1時間撹拌
し、反応を終了した。反応溶液を室温で濃縮し、その残
留物にエタノール(100ml)を加え、溶解した後、メ
チルアミン 40%メタノール溶液(10.0g,14
0.0mmol) を滴下し、50℃で一時間撹拌した。反応
溶液を再び減圧濃縮し、その残留物を酢酸エチルで抽出
した。有機層を12%塩酸、蒸留水、炭酸水素ナトリウム
水溶液、飽和食塩水で順次洗浄し、無水硫酸ナトリウム
で乾燥した。濾過後、減圧濃縮したところ、褐色油状物
質が得られた。これをシルカゲルカラムクロマトグラフ
ィーに付し、クロロホルム−メタノール混合溶媒で溶出
し、減圧濃縮した後、残留物を酢酸エチル−n−ヘキサ
ンで再結晶したところ、白色粉末結晶として、4−ヒド
ロキシ−n−(2−ヒドロキシフェニル)安息香酸アミ
ド(5.02g,45%)(化合物1)が得られた。 mp.159.1-159.7℃ NMR:(DMSO-d6):δ;ppm 6.78-7.06(m,2H),6.88(d,2H,J=10Hz),7.04(d,1H,J=7H
z),7.71(d,1H,J=7Hz),7.87(d,2H,J=10Hz),9.37(s,1H),
9.76(s,1H),10.13(s,1H) IR:(KBr):cm-1 3616,3340,2956,1641,1515,1434,828
Synthesis Example 1 o-Aminophenol (10.99 g, 100.0 mmo
l) is a pyridine-chloroform (5: 1) mixed solvent (1
A solution of p-acetoxybenzoic acid chloride (10.0 g, 50.0 mmol) dissolved in chloroform (200 ml) was slowly added dropwise over 3.5 hours. After completion of dropping, the reaction was completed by further stirring for 1 hour. The reaction solution was concentrated at room temperature, ethanol (100 ml) was added to the residue and dissolved, and then methylamine 40% methanol solution (10.0 g, 14
0.0 mmol) was added dropwise and the mixture was stirred at 50 ° C. for 1 hour. The reaction solution was concentrated again under reduced pressure, and the residue was extracted with ethyl acetate. The organic layer was washed successively with 12% hydrochloric acid, distilled water, aqueous sodium hydrogen carbonate solution and saturated brine, and dried over anhydrous sodium sulfate. After filtration and concentration under reduced pressure, a brown oily substance was obtained. This was subjected to silica gel column chromatography, eluted with a chloroform-methanol mixed solvent, concentrated under reduced pressure, and the residue was recrystallized from ethyl acetate-n-hexane to give 4-hydroxy-n as white powder crystals. -(2-Hydroxyphenyl) benzoic acid amide (5.02 g, 45%) (Compound 1) was obtained. mp.159.1-159.7 ° C NMR: (DMSO-d 6 ): δ; ppm 6.78-7.06 (m, 2H), 6.88 (d, 2H, J = 10Hz), 7.04 (d, 1H, J = 7H
z), 7.71 (d, 1H, J = 7Hz), 7.87 (d, 2H, J = 10Hz), 9.37 (s, 1H),
9.76 (s, 1H), 10.13 (s, 1H) IR: (KBr): cm -1 3616,3340,2956,1641,1515,1434,828

【0024】合成例2 合成例1と同様にして4−ヒドロキシ−N−(3−ヒド
ロキシフェニル)ベンズアミド(化合物2)を得た(3
5%)。 mp.230-231℃ NMR:(DMSO-d6):δ;ppm 6.87(d,1H,J=8Hz),6.93(d,2H,J=8Hz),7.38(t,1H,J=8H
z),7.64(d,1H,J=8Hz),7.76(s,1H),7.86(d,1H,J=8Hz),8.
00(d,1H,J=8Hz),10.00(br.s,2H),10.13(s,1H)
Synthesis Example 2 4-hydroxy-N- (3-hydroxyphenyl) benzamide (Compound 2) was obtained in the same manner as in Synthesis Example 1 (3).
5%). mp.230-231 ° C NMR: (DMSO-d 6 ): δ; ppm 6.87 (d, 1H, J = 8Hz), 6.93 (d, 2H, J = 8Hz), 7.38 (t, 1H, J = 8H)
z), 7.64 (d, 1H, J = 8Hz), 7.76 (s, 1H), 7.86 (d, 1H, J = 8Hz), 8.
00 (d, 1H, J = 8Hz), 10.00 (br.s, 2H), 10.13 (s, 1H)

【0025】合成例3 合成例1と同様にして4−ビドロキシ−N−(4−ヒド
ロキシフェニル)ベンズアミド(化合物3)を得た(6
1%)。 mp.276.1℃( 自動融点測定) NMR:(DMSO-d6):δ;ppm 6.71(d,2H,J=9Hz),6.82(d,2H,J=8Hz),7.43(d,2H,J=9H
z),7.81(d,2H,J=8Hz),9.17(s,1H),9.74(s,1H),10.00(s,
1H)
Synthesis Example 3 In the same manner as in Synthesis Example 1, 4-vidroxy-N- (4-hydroxyphenyl) benzamide (Compound 3) was obtained (6)
1%). mp.276.1 ° C (automatic melting point measurement) NMR: (DMSO-d 6 ): δ; ppm 6.71 (d, 2H, J = 9Hz), 6.82 (d, 2H, J = 8Hz), 7.43 (d, 2H, J = 9H
z), 7.81 (d, 2H, J = 8Hz), 9.17 (s, 1H), 9.74 (s, 1H), 10.00 (s,
1H)

【0026】合成例4 3,5−ジ−t−ブチル−4−ヒドロキシ安息香酸
(6.26g,25.0mmol) 及び p−アミノフェノ
ール(2.73g,25.0mmol)を酢酸エチル−ジメ
チルホルムアミド(4:1)混合溶媒(60ml)中に溶
解し、0℃で撹拌しながらN,N1−ジシクロヘキシカ
ルボジイミド(5.16g,25.0mmol)を酢酸エチ
ル(20ml) に溶解させたものを加えた。1時間後、室
温に戻し、さらに2時間撹拌し、反応を終了した。反応
溶液を濾過し、ウレアを除去した後、クロロホルムで抽
出した。有機層を、3%塩酸、炭酸水素ナトリウム水溶
液、飽和食塩水で順次洗浄し、減圧濃縮した。残留物
を、メタノール−エーテルに溶解し、遊離するウレアを
濾別し、溶液を再度濃縮し、さらに酢酸エチル−エーテ
ル−n−ヘキサン混合溶媒で再結晶したところ、白色結
晶として3,5−ジ−t−ブチル−4−ヒドロキシ−N
−(4−ヒドロキシフェニル)ベンズアミド(5.18
g,61%)(化合物4)が得られた。 mp.237-241℃ NMR:(DMSO-d6):δ;ppm 1.43(s,18H),6.73(d,2H,J=9Hz),7.45(d,2H,J=9Hz),7.50
(br.s,1H),7.65(s,2H),9.18(br.s,1H),9.80(s,1H) IR:(KBr):cm-1 3616,3340,2956,1641,1515,1430,828
Synthesis Example 4 3,5-Di-t-butyl-4-hydroxybenzoic acid (6.26 g, 25.0 mmol) and p-aminophenol (2.73 g, 25.0 mmol) were mixed with ethyl acetate-dimethylformamide. (4: 1) dissolved in a mixed solvent (60 ml), and N, N 1 -dicyclohexylcarbodiimide (5.16 g, 25.0 mmol) dissolved in ethyl acetate (20 ml) with stirring at 0 ° C. Was added. After 1 hour, the temperature was returned to room temperature and stirring was continued for 2 hours to complete the reaction. The reaction solution was filtered to remove urea and then extracted with chloroform. The organic layer was washed successively with 3% hydrochloric acid, aqueous sodium hydrogen carbonate solution and saturated brine, and concentrated under reduced pressure. The residue was dissolved in methanol-ether, free urea was filtered off, the solution was concentrated again, and recrystallized with a mixed solvent of ethyl acetate-ether-n-hexane. -T-butyl-4-hydroxy-N
-(4-hydroxyphenyl) benzamide (5.18
g, 61%) (compound 4) was obtained. mp.237-241 ° C NMR: (DMSO-d 6 ): δ; ppm 1.43 (s, 18H), 6.73 (d, 2H, J = 9Hz), 7.45 (d, 2H, J = 9Hz), 7.50
(br.s, 1H), 7.65 (s, 2H), 9.18 (br.s, 1H), 9.80 (s, 1H) IR: (KBr): cm -1 3616,3340,2956,1641,1515,1430 , 828

【0027】合成例5 合成例4と同様にして3,5−ジ−t−ブチル−4−ヒ
ドロキシ−N−(3−ヒドロキシフェニル)ベンズアミ
ド(化合物5)を得た(20%)。 mp.237-241℃ NMR:(DMSO-d6):δ;ppm 1.44(s,18H),6.42-6.51(m,1H),7.13-7.04(m,2H),7.29
(s,1H),7.47(br.s,1H),7.64(s,2H),9.33(br.s,1H),9.90
(s,1H)
Synthesis Example 5 3,5-Di-t-butyl-4-hydroxy-N- (3-hydroxyphenyl) benzamide (Compound 5) was obtained in the same manner as in Synthesis Example 4 (20%). mp.237-241 ° C NMR: (DMSO-d 6 ): δ; ppm 1.44 (s, 18H), 6.42-6.51 (m, 1H), 7.13-7.04 (m, 2H), 7.29
(s, 1H), 7.47 (br.s, 1H), 7.64 (s, 2H), 9.33 (br.s, 1H), 9.90
(s, 1H)

【0028】合成例6 合成例4と同様にして3,5−ジ−t−ブチル−4−ヒ
ドロキシ−N−(2−ヒドロキシフェニル)ベンズアミ
ド(化合物6)を得た(50%)。 mp.237-241℃ NMR:(DMSO-d6):δ;ppm 1.44(s,18H),6.79-7.06(m,2H),7.00(d,1H,J=8Hz),7.53
(br.s,1H),7.64(d,1H,J=8Hz),7.72(s,2H),9.47(s,1H),
9.67(br.s,1H) IR:(KBr):cm-1 3620,3334,2962,1638,1605,1533,1455,1368,1239,750
Synthesis Example 6 In the same manner as in Synthesis Example 4, 3,5-di-t-butyl-4-hydroxy-N- (2-hydroxyphenyl) benzamide (Compound 6) was obtained (50%). mp.237-241 ° C NMR: (DMSO-d 6 ): δ; ppm 1.44 (s, 18H), 6.79-7.06 (m, 2H), 7.00 (d, 1H, J = 8Hz), 7.53
(br.s, 1H), 7.64 (d, 1H, J = 8Hz), 7.72 (s, 2H), 9.47 (s, 1H),
9.67 (br.s, 1H) IR: (KBr): cm -1 3620,3334,2962,1638,1605,1533,1455,1368,1239,750

【0029】実施例1 合成例1〜6で得られた化合物1〜6をそれぞれ1重量
%含有するエタノール溶液を調製し、以下の試験に供し
た。
Example 1 An ethanol solution containing 1% by weight of each of the compounds 1 to 6 obtained in Synthesis Examples 1 to 6 was prepared and subjected to the following tests.

【0030】(試験1) ヘアレスマウスによるシワ形成抑制試験:ヘアレスマウ
ス(HR/ICR、実験開始時6週齢)の背部に安息香
酸アニリド類(1)のエタノール溶液を80μl 塗布し
た。2時間後エタノールで皮膚表面上の安息香酸アニリ
ド類(1)を拭き取り、健康線用ランプ(東芝製、SE
20)を6本使用し、1回の照射量が1MED以下とな
るように調節してUVB光の照射を行い、週5回の照射
を8週間にわたって行った。照射のエネルギー量をUV
−Radiometer(TOKYO OPTICAL
社製、UVR−305/365D)を用いて測定した。
また、コントロールとしてエタノールのみを塗布したも
のをサンプルと同様に塗布した。試験終了後、形成され
たシワの度数を肉眼により下記の基準(シワ指数)で評
価した。その結果を表1に示す。
(Test 1) Wrinkle formation inhibition test by hairless mouse: 80 μl of an ethanol solution of anilide benzoic acid (1) was applied to the back of a hairless mouse (HR / ICR, 6 weeks old at the start of the experiment). After 2 hours, wipe off the benzoyl anilides (1) on the surface of the skin with ethanol, and use a health line lamp (TOSHIBA, SE
20) was used, and UVB light irradiation was carried out by adjusting the irradiation amount once to 1 MED or less, and irradiation was carried out 5 times a week for 8 weeks. UV irradiation energy amount
-Radiometer (TOKYO OPTICAL
UVR-305 / 365D manufactured by the company) was used for the measurement.
Further, as a control, a sample coated with ethanol alone was coated in the same manner as the sample. After the test was completed, the frequency of the wrinkles formed was visually evaluated according to the following criteria (wrinkle index). Table 1 shows the results.

【0031】シワ指数: 0:シワが無形成 1:シワがかすかに形成 2:シワが微量形成 3:シワが若干形成 4:シワが強固に形成Wrinkle index: 0: No wrinkles formed 1: Wrinkles formed slightly 2: Wrinkles formed in a small amount 3: Wrinkles slightly formed 4: Wrinkles formed strongly

【0032】(試験2) シワの解析:試験1において形成されたシワを詳細に解
析するため、各マウスについてハイドロフィリックエク
ザフレックス親水性ビニルシリコーン印像剤を用いて、
直径1cmの円形に3か所から皮膚のレプリカを採取し
た。このレプリカを水平状態において30°方向から光
を照射し、シワによってできる影の割合を画像解析装置
を用いて面積率として求めた。この結果も表1に示す。
(Test 2) Analysis of wrinkles: In order to analyze the wrinkles formed in Test 1 in detail, a hydrophilic Exaflex hydrophilic vinyl silicone image-forming agent was used for each mouse.
Skin replicas were collected from three locations in a circle with a diameter of 1 cm. This replica was irradiated with light from a 30 ° direction in a horizontal state, and the ratio of shadows formed by wrinkles was obtained as an area ratio using an image analyzer. The results are also shown in Table 1.

【0033】[0033]

【表1】 [Table 1]

【0034】(試験3) 褐色モルモット背部のUVBによる色素沈着に対する効
果:褐色モルモットの背部毛をバリカンとシェーバーに
て丁寧に剃毛したのち、1.5cm四方に8分割する。各
々の部位に評価試料(100mM,20μl)を塗布し、
その2時間後に塗布した試料をエタノールで拭き取り、
UVB領域の紫外線を最小紅斑量(MED)の2倍量を
照射する。UV照射後再度評価試料(100mM,20μ
l)を塗布する。この操作を3日間繰り返す。それ以降
は試料(100mM,10μl)のみ1週間連続塗布し、
2週間後に色素沈着量を調べた。尚、コントロールとし
て、試料のかわりにエタノールを塗布した。評価は、色
差計により測定を行い、得られたマンセル値からL*
を算出し、下記式の如くUVB照射2週間後のL*値か
らUVB照射前のL*値を差し引いた値(ΔL*)を求
め、色素沈着の程度を比較した。−ΔL*値が大きいほ
ど色素沈着の程度が強いことを示す。
(Test 3) Effect of UVB pigmentation on the back of the brown guinea pig: The back hair of the brown guinea pig is carefully shaved with a hair clipper and a shaver, and then it is divided into eight 1.5 cm squares. Apply an evaluation sample (100 mM, 20 μl) to each site,
2 hours later, wipe the applied sample with ethanol,
Ultraviolet rays in the UVB region are irradiated at twice the minimum erythema dose (MED). After UV irradiation, re-evaluate sample (100 mM, 20μ
l) is applied. This operation is repeated for 3 days. After that, only the sample (100 mM, 10 μl) was applied continuously for 1 week,
The amount of pigmentation was examined after 2 weeks. As a control, ethanol was applied instead of the sample. The evaluation was carried out by measuring with a color difference meter, the L * value was calculated from the obtained Munsell value, and the value obtained by subtracting the L * value before UVB irradiation from the L * value 2 weeks after UVB irradiation as shown below (ΔL * ) Was calculated and the degree of pigmentation was compared. The larger the -ΔL * value, the stronger the degree of pigmentation.

【0035】[0035]

【数1】 ΔL*=UVB照射後のL*値−UVB照射前のL*[Number 1] ΔL * = after UVB irradiation L * value -UVB before irradiation of the L * value

【0036】この結果を表2に示す。The results are shown in Table 2.

【0037】[0037]

【表2】 [Table 2]

【0038】以上の結果より本試料が優れた色素沈着抑
制作用を有することが示された。
From the above results, it was shown that this sample has an excellent pigmentation inhibiting effect.

【0039】以下、実施例2〜4において、それぞれの
組成の化粧料を常法により混合して製造した。
Hereinafter, in Examples 2 to 4, the cosmetics having the respective compositions were mixed and manufactured by a conventional method.

【0040】[0040]

【表3】 実施例2.クリーム: 化合物6 0.2(重量%) コレステロール 0.5 コレステロールイソステアレート 1 ポリエーテル変性シリコーン 1.5 環状シリコーン 20 メチルフェニルポリシロキサン 2 メチルポリシロキサン 2 硫酸マグネシウム 0.5 55%エタノール 5 カルボキシメチルキチン 0.5 アラントイン 1 香料,色素 微量 精製水 バランス 計 100.0Table 3 Example 2. Cream: Compound 6 0.2 (wt%) Cholesterol 0.5 Cholesterol isostearate 1 Polyether-modified silicone 1.5 Cyclic silicone 20 Methylphenylpolysiloxane 2 Methylpolysiloxane 2 Magnesium sulfate 0.5 55% Ethanol 5 Carboxymethyl Chitin 0.5 Allantoin 1 Fragrance, pigment Micro purified water Balance meter 100.0

【0041】[0041]

【表4】 実施例3.スキンローション: 化合物6 2(重量%) グリセリンモノステアレート 1 エタノール 15 プロピレングリコール 4 イソプロピルパルミテート 3 ラノリン 1 パラオキシ安息香酸メチル 0.1 香料,色素 微量 精製水 73.9 計 100.0Table 4 Example 3. Skin lotion: Compound 6 2 (wt%) Glycerin monostearate 1 Ethanol 15 Propylene glycol 4 Isopropyl palmitate 3 Lanolin 1 Methyl paraoxybenzoate 0.1 Perfume, pigment Micro purified water 73.9 Total 100.0

【0042】[0042]

【表5】 実施例4.パック剤: 化合物6 4(重量%) ポリビニルアルコール 20 グリセリン 5 エタノール 16 香料,色素 微量 精製水 55 計 100.0Table 5 Example 4. Packing agent: Compound 64 (% by weight) Polyvinyl alcohol 20 Glycerin 5 Ethanol 16 Perfume, dye Micro purified water 55 Total 100.0

───────────────────────────────────────────────────── フロントページの続き (72)発明者 大須 弘之 栃木県芳賀郡市貝町赤羽2606−6 (72)発明者 時光 一郎 栃木県宇都宮市竹林町89−28 ─────────────────────────────────────────────────── ─── Continued Front Page (72) Inventor Hiroyuki Osu 2606-6 Akabane, Kai-cho, Haga-gun, Tochigi Prefecture (72) Inventor Ichiro Tokimitsu 89-28 Takebayashi-cho, Utsunomiya-shi, Tochigi Prefecture

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 次の一般式(1) 【化1】 〔式中、R1 は水素原子又はt−ブチル基を示し、R2
は水素原子又は炭素数1〜5のアルキル若しくはアシル
基を示す〕で表わされる安息香酸アニリド類又はその塩
を含有する皮膚化粧料。
1. The following general formula (1): [In the formula, R 1 represents a hydrogen atom or a t-butyl group, and R 2
Represents a hydrogen atom or an alkyl or acyl group having 1 to 5 carbon atoms], and a skin cosmetic containing the anilide benzoate or a salt thereof.
JP32534094A 1994-12-27 1994-12-27 Skin cosmetic Pending JPH08175959A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP32534094A JPH08175959A (en) 1994-12-27 1994-12-27 Skin cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32534094A JPH08175959A (en) 1994-12-27 1994-12-27 Skin cosmetic

Publications (1)

Publication Number Publication Date
JPH08175959A true JPH08175959A (en) 1996-07-09

Family

ID=18175718

Family Applications (1)

Application Number Title Priority Date Filing Date
JP32534094A Pending JPH08175959A (en) 1994-12-27 1994-12-27 Skin cosmetic

Country Status (1)

Country Link
JP (1) JPH08175959A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100786300B1 (en) * 2006-09-19 2007-12-18 (주)아모레퍼시픽 Antiaging cosmetic composition containing 4-substituted benzoic acid derivatives having 3,4-methylene- or 3,4-ethylenedixoybenzene moiety
WO2008047758A1 (en) * 2006-10-17 2008-04-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Antiinflammatory agent comprising 2-aminophenol or derivative thereof as active ingredient
WO2010110353A1 (en) * 2009-03-25 2010-09-30 味の素株式会社 Novel amide derivative and skin whitening agent
JP2014529583A (en) * 2011-08-05 2014-11-13 株式会社アモーレパシフィックAmorepacific Corporation New benzoic acid amide compounds

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100786300B1 (en) * 2006-09-19 2007-12-18 (주)아모레퍼시픽 Antiaging cosmetic composition containing 4-substituted benzoic acid derivatives having 3,4-methylene- or 3,4-ethylenedixoybenzene moiety
WO2008035904A1 (en) * 2006-09-19 2008-03-27 Amorepacific Corporation Method for processing 4-substituted benzoic acid derivatives having 3, 4-methylene- or 3,4-ethylenedioxybenzene moiety and the use of the same for antiaging cosmetics
WO2008047758A1 (en) * 2006-10-17 2008-04-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Antiinflammatory agent comprising 2-aminophenol or derivative thereof as active ingredient
JP5357545B2 (en) * 2006-10-17 2013-12-04 株式会社林原 Anti-inflammatory agent containing 2-aminophenol or its derivative as an active ingredient
WO2010110353A1 (en) * 2009-03-25 2010-09-30 味の素株式会社 Novel amide derivative and skin whitening agent
US9295624B2 (en) 2009-03-25 2016-03-29 Ajinomoto Co., Inc. Amide derivative and whitening agent
JP2014529583A (en) * 2011-08-05 2014-11-13 株式会社アモーレパシフィックAmorepacific Corporation New benzoic acid amide compounds

Similar Documents

Publication Publication Date Title
CN105050575A (en) Combination of alkylamidothiazoles and preservatives
TW561052B (en) Composition for depigmenting and/or bleaching human skin and/or for removing skin pigmentation marks comprising oxamate derivatives
JP4393064B2 (en) How to use tyramine as a cosmetic ingredient to make white skin
JPH05306231A (en) Skin external preparation
JPH08175960A (en) Wrinkle-preventing cosmetic
CN105007991A (en) Combinations of alkylamidothiazoles and aromatic substances
JP3340935B2 (en) Melanin production inhibitor and whitening cosmetic
JPH11286423A (en) Composition for suppressing body odor
JP3753188B2 (en) Novel salicylic acid derivatives and their use in cosmetic and / or dermatological compositions
JPH09176138A (en) New l-oxothiazolidine-4-carboxylic acid derivative and its use for skin care
JPH1067615A (en) Pigment eliminator consisting of n,n&#39;-dibenzylethylenediamine-n,n&#39;-diacetic acid derivative
JP6760939B2 (en) Compounds of the N-acylamino-amide family, compositions containing them, and uses
JPH08175959A (en) Skin cosmetic
JP2001010926A (en) Bleaching agent
JPH05105643A (en) Cinnamic acid derivative and skin-beautifying cosmetic containing the derivative as active component
JP3071990B2 (en) External preparation for skin
JPH05105621A (en) Beautifying cosmetic comprising cinnamic ester derivative as active ingredient
JPH11292752A (en) Beautifully whitening agent and composition for external use for skin
JP4235602B2 (en) Melanin production inhibitor and topical skin preparation
JP4004426B2 (en) Skin activation external composition
JP3477266B2 (en) Anti-aging skin cosmetics
JPH05345713A (en) External preparation for skin
JPH0977651A (en) Beautifying and whitening cosmetic
JP3404175B2 (en) Skin cosmetics
JPH0848621A (en) Skin whitening cosmetic